Back to Susquehanna International Group, LLP Susquehanna International Group, LLP

SAVASAVA

Showing 8 of 30 quarters

Position history for Susquehanna International Group, LLPSusquehanna International Group, LLP's holdings in FILANA THERAPEUTICS INC

Yes. Susquehanna International Group holds 292,017 shares of SAVA (Filana Therapeutics), worth $347,501, as of its Q2 2026 13F filing. It reduced the position by 155,261 shares (-34.7%) from Q1 2026. Susquehanna International Group has held SAVA since Q1 2020, across 26 quarterly 13F filings.

Current Value

$347,501

Current Shares

292,017

Total Value Change

-$1.4M

Total Shares Change

+231,132

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
292,017
-34.7%
$347,5010.0%$1.19
0
2026-Q1
Decreased
447,278
-15.3%
$755,9000.0%$1.69
0
2025-Q4
Increased
528,018
+38.2%
$1M0.0%$1.98
33
2025-Q3
Decreased
382,018
-14.4%
$1.1M0.0%$2.91
0
2025-Q2
Decreased
446,430
-19.1%
$808,0380.0%$1.81
0
2025-Q1
Increased
552,021
+96.9%
$828,0320.0%$1.50
40
2024-Q4
Increased
280,393
+360.5%
$661,7270.0%$2.36
40
2024-Q3
Decreased
60,885
-91.2%
$1.8M0.0%$29.43
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used